NYSE - Delayed Quote USD

Haemonetics Corporation (HAE)

87.66 +1.44 (+1.67%)
At close: April 25 at 4:00 PM EDT
87.66 0.00 (0.00%)
After hours: April 25 at 7:59 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,270,181.00
1,168,660.00
993,196.00
870,463.00
Cost of Revenue
598,290.00
553,563.00
487,694.00
472,625.00
Gross Profit
671,891.00
615,097.00
505,502.00
397,838.00
Operating Expense
491,659.00
459,446.00
434,355.00
340,903.00
Operating Income
180,232.00
155,651.00
71,147.00
56,935.00
Net Non Operating Interest Income Expense
-9,118.00
-14,630.00
-17,121.00
-16,834.00
Other Income Expense
--
382.00
9,603.00
32,812.00
Pretax Income
161,077.00
141,403.00
63,629.00
72,913.00
Tax Provision
34,503.00
26,002.00
20,254.00
-6,556.00
Net Income Common Stockholders
126,574.00
115,401.00
43,375.00
79,469.00
Diluted NI Available to Com Stockholders
126,574.00
115,401.00
43,375.00
79,469.00
Basic EPS
2.50
2.27
0.85
1.57
Diluted EPS
2.46
2.24
0.84
1.55
Basic Average Shares
50,620.25
50,783.00
51,047.00
50,688.00
Diluted Average Shares
51,350.25
51,420.00
51,353.00
51,292.00
Total Operating Income as Reported
170,195.00
156,033.00
80,750.00
89,747.00
Total Expenses
1,089,949.00
1,013,009.00
922,049.00
813,528.00
Net Income from Continuing & Discontinued Operation
126,574.00
115,401.00
43,375.00
79,469.00
Normalized Income
134,461.06
115,089.29
36,825.75
55,516.24
Interest Expense
9,118.00
14,630.00
17,121.00
16,834.00
Net Interest Income
-9,118.00
-14,630.00
-17,121.00
-16,834.00
EBIT
170,195.00
156,033.00
80,750.00
89,747.00
EBITDA
263,625.00
249,340.00
178,497.00
174,034.00
Reconciled Cost of Revenue
534,440.00
492,896.00
437,361.00
421,168.00
Reconciled Depreciation
93,430.00
93,307.00
97,747.00
84,287.00
Net Income from Continuing Operation Net Minority Interest
126,574.00
115,401.00
43,375.00
79,469.00
Total Unusual Items Excluding Goodwill
-10,037.00
382.00
9,603.00
32,812.00
Total Unusual Items
-10,037.00
382.00
9,603.00
32,812.00
Normalized EBITDA
273,662.00
248,958.00
168,894.00
141,222.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,149.94
70.29
3,053.75
8,859.24
3/31/2021 - 5/10/1991

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MMSI Merit Medical Systems, Inc.
73.38
-0.88%
 
ICUI ICU Medical, Inc.
94.53
-2.26%
 
TFX Teleflex Incorporated
206.71
-2.11%
 
UTMD Utah Medical Products, Inc.
66.29
-1.30%
 
ANGO AngioDynamics, Inc.
5.78
-1.53%
 
ATRC AtriCure, Inc.
22.61
-1.91%
 
ATRI Atrion Corporation
398.97
-5.95%
 
EMBC Embecta Corp.
10.40
-4.50%
 
LMAT LeMaitre Vascular, Inc.
62.99
-1.62%
 
STVN Stevanato Group S.p.A.
27.52
+0.77%